Prolocor Inc | Finanzwire

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Prolocor Inc

BRIEF

published on 10/21/2024 at 17:05, 2 months ago

Prolocor Unveils Results of Multicenter Study on Cardiovascular Risk in JACC

Prolocor PFCG® Test Cardiovascular Risk Antithrombotic Treatment JACC Publication Individualized Therapy
PRESS RELEASE

published on 10/21/2024 at 17:00, 2 months ago

Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Prolocor, Inc. announces publication of results from a confirmatory 800 patient ACS trial in JACC, showing a >2-fold predictive value for heart attack, stroke, and death. The Prolocor pFCG® test supports individualized antiplatelet therapy

Prolocor Inc. JACC Publication ACS Trial PFCG Test Antiplatelet Therapy
BRIEF

published on 09/05/2024 at 14:05, 3 months 16 days ago

Prolocor and Slingshot Biosciences Announce Publication in Bioanalysis

Prolocor PFCG® Test Thrombosis Prognosis TruCytes Cell Mimics Heart Attack Risk Precision Diagnostics
PRESS RELEASE

published on 09/05/2024 at 14:00, 3 months 16 days ago

Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis
Study in Bioanalysis shows Prolocor pFCG® test as reliable tool for thrombosis risk assessment with TruCytes cell mimics, accurate and precise. Partnership between Prolocor Inc. and Slingshot Biosciences

Partnership Prolocor PFCG® Test TruCytes Cell Mimics Thrombosis Risk Bioanalysis Study
BRIEF

published on 02/27/2024 at 15:00, 9 months 23 days ago

Prolocor raises $1.7 million for an accurate thrombosis risk diagnostic program

Funding Prolocor Thrombosis Medical Innovation Diagnostic
PRESS RELEASE

published on 02/27/2024 at 15:00, 9 months 23 days ago

Prolocor Announces $1.7 Million in Bridge Funding
Prolocor, Inc. raises $1.7 million in bridge financing to advance precision diagnostic test for predicting thrombosis risk. Funding from GPG Ventures and Labcorp Venture Fund

Bridge Financing Prolocor Inc. Precision Diagnostic Test Thrombosis Risk Prediction GPG Ventures
BRIEF

published on 02/20/2024 at 15:00, 10 months 1 day ago

Prolocor, Inc. Introduces a Breakthrough in Thrombosis Risk Diagnosis

Prolocor Thrombosis Precision Diagnosis Cardiology Medical Innovation
PRESS RELEASE

published on 02/20/2024 at 15:00, 10 months 1 day ago

Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)
Prolocor, Inc. announces acceptance of abstract on platelet FcγRIIa implications in myocardial infarction treatment strategy at ACC Scientific Sessions 2024

Prolocor Inc. Platelet FcγRIIa Myocardial Infarction Treatment Strategy Clinical Program

Accesswire

Published on 12/21/2024 at 01:30, 18 hours 9 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 9 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 34 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 39 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 20 hours 9 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 47 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 54 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 21 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days 1 hour ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE